Evidence map›Paper›PMID 20623566›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2010

Preactivation-based, one-pot combinatorial synthesis of heparin-like hexasaccharides for the analysis of heparin-protein interactions.

Zhen Wang, Yongmei Xu, Bo Yang, Gopinath Tiruchinapally, Bin Sun, Renpeng Liu, Steven Dulaney, Jian Liu, Xuefei Huang

Open access · bronzeAbstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Synthesis of Sulfated Carbohydrates - Glycosaminoglycans.Handbook of experimental pharmacology · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Synthesis of a Systematic 64-Membered Heparan Sulfate Tetrasaccharide Library.Angewandte Chemie (International ed. in English) · 2023
    Article
  7. Article
  8. Article
  9. Automated Solid Phase Assisted Synthesis of a Heparan Sulfate Disaccharide Library.Organic chemistry frontiers : an international journal of organic chemistry · 2022
    Article
  10. Chemical editing of proteoglycan architecture.Nature chemical biology · 2022
    Article
  11. Article
  12. Review
  13. Total synthesis of aBeilstein journal of organic chemistry · 2017
    Article
  14. Article
  15. Automated glycan assembly of a S. pneumoniae serotype 3 CPS antigen.Beilstein journal of organic chemistry · 2016
    Article
  16. Divergent Synthesis of Heparan Sulfate Oligosaccharides.The Journal of organic chemistry · 2015
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zhen WangDepartment of Chemistry, Michigan State University, East Lansing, MI 48824, USA.
Yongmei Xu
Bo Yang
Gopinath Tiruchinapally
Bin Sun
Renpeng Liu
Steven Dulaney
Jian Liu
Xuefei Huang
Michigan State University · USUniversity of North Carolina at Chapel Hill · US

Funding

Homogeneous Heparan Sulfate Glycopeptides: Synthetic and Functional StudiesR01GM072667 · NIGMS · UNIVERSITY OF TOLEDO · PI HUANG, XUEFEI · 2005 to 2024
$5.1M
NIGMS NIH HHS R01 GM072667NIGMS NIH HHS R01-GM-72667
6 · The paper itself

Abstract

Heparin (HP) and heparan sulfate (HS) play important roles in many biological events. Increasing evidence has shown that the biological functions of HP and HS can be critically dependent upon their precise structures, including the position of the iduronic acids and sulfation patterns. However, unraveling the HP code has been extremely challenging due to the enormous structural variations. To overcome this hurdle, we investigated the possibility of assembling a library of HP/HS oligosaccharides using a preactivation-based, one-pot glycosylation method. A major challenge in HP/HS oligosaccharide synthesis is stereoselectivity in the formation of the cis-1,4-linkages between glucosamine and the uronic acid. Through screening, suitable protective groups were identified on the matching glycosyl donor and acceptor, leading to stereospecific formation of both the cis-1,4- and trans-1,4-linkages present in HP. The protective group chemistry designed was also very flexible. From two advanced thioglycosyl disaccharide intermediates, all of the required disaccharide modules for library preparation could be generated in a divergent manner, which greatly simplified building-block preparation. Furthermore, the reactivity-independent nature of the preactivation-based, one-pot approach enabled us to mix the building blocks. This allowed rapid assembly of twelve HP/HS hexasaccharides with systematically varied and precisely controlled backbone structures in a combinatorial fashion. The speed and the high yields achieved in glycoassembly without the need to use a large excess of building blocks highlighted the advantages of our approach, which can be of general use to facilitate the study of HP/HS biology. As a proof of principle, this panel of hexasaccharides was used to probe the effect of backbone sequence on binding with the fibroblast growth factor-2 (FGF-2). A trisaccharide sequence of 2-O-sulfated iduronic acid flanked by N-sulfated glucosamines was identified to be the minimum binding motif and N-sulfation was found to be critical. This provides useful information for further development of more potent compounds towards FGF-2 binding, which can have potential applications in wound healing and anticancer therapy.

Indexed as

GlycosylationHeparan SulfateHeparinKineticsMolecular Sequence DataMolecular StructureOligosaccharidesProtein BindingStereoisomerismHeparan SulfateHeparinOligosaccharides

Identifiers

PMID20623566
PMCPMC3094016
OpenAlexW2014604280

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.